Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
- 72789430 Label - 72789430
- Chemical Structure - tadalafil 1
- Tadalafil-tablets-figure-1 - tadalafil 2
- Tadalafil-tablets-figure-2 - tadalafil 3
- Tadalafil-tablets-figure-3 - tadalafil 4
- Tadalafil-tablets-figure-4 - tadalafil 5
- Table 5 - tadalafil 6
- Table 6 - tadalafil 7
- Tadalafil-tablets-figure-7 - tadalafil 8
- Image 8 - tadalafil 9
Product Label Images
The following 10 images provide visual information about the product associated with Tadalafil NDC 72789-430 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
72789430 Label - 72789430
This is not-available.*
Chemical Structure - tadalafil 1
Tadalafil-tablets-figure-1 - tadalafil 2
This text mentions the difference in blood pressure values between Tadalafil and Placebo, specifically for standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure over time (in hours). It seems to be a comparison of the impact of Tadalafil on blood pressure compared to a placebo.*
Tadalafil-tablets-figure-2 - tadalafil 3
Tadalafil-tablets-figure-3 - tadalafil 4
This text contains information about a study comparing the effects of different treatments on systolic blood pressure at different time points. The treatments evaluated include tadalafil and doxazosin at various doses and timings. The data presented may be useful for analyzing the impact of these medications on blood pressure regulation.*
Tadalafil-tablets-figure-4 - tadalafil 5
This text shows a table displaying plasma Tadalafil concentration in micrograms per liter over time for different doses and administration schedules. The data includes a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose for 5 consecutive days. Time points of measurement are at 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 hours post-administration. These values can be used for pharmacokinetic analysis of Tadalafil.*
Table 5 - tadalafil 6
Table 6 - tadalafil 7
Tadalafil-tablets-figure-7 - tadalafil 8
The text appears to show data related to the LS mean change from baseline over weeks of therapy for both the placebo and finasteride groups. It is indicating statistical significance levels for the data.*
Image 8 - tadalafil 9
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
